Compare FMC Corp (FMC) vs Workiva Inc (WK) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Workiva (WK) stock trades at $56.86, up 5.9% in the last session, reflecting strong momentum. The technical picture is bullish with price above key moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, the company has beaten earnings estimates for three consecutive quarters and shows improving revenue growth, though profitability metrics remain thin with a net margin of 1.53%. Analyst sentiment is overwhelmingly positive with an 88.9% buy rating and a $71 consensus price target.

The outlook is positive based on consistent earnings beats, strong analyst support, and projected revenue and profit growth into 2026. Key opportunities include the company's dominant position in compliance software and AI-powered platform expansion. Primary risks involve high valuation multiples (P/E of 226.6), thin current profitability, and execution pressure to meet elevated growth expectations.